In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Keeping the Workforce: the Drug Industry's Cognitive Dissonance Problem

Executive Summary

Amidst the mounting attacks on the drug industry by respected mass market publications and broadcast news, it is growing increasingly difficult for those in the industry to maintain the personal mission of "doing good" that--at least partly--attracted them to the pharmaceutical business. In the past, attractive option packages might have helped executives deal with uneasiness about some of the strategies being pursued by companies under the gun of blockbuster economics. But with stock prices low, that source of comfort has been removed--raising doubts about the industry's ability to retain its best and brightest.

You may also be interested in...



The Value of Me-Too's in the Context of OTC Switches

At Windhover's annual Marketing Pharmaceutical Innovation (MPI) conference in November, industry executives wrestled with an emerging dilemma -- how to win managed care's support for drugs that exhibit only minor improvements to existing products, while new over-the-counter (OTC) options surface.

Coronavirus Notebook: EMA Issues Guidance On Development Of Variant Vaccines, EU Leaders Urge Production Ramp-Up

A batch of AstraZeneca/Oxford University coronavirus vaccines has arrived in Ghana, the first country in the world to receive vaccines via the COVAX Facility. 

Start-Up Scanwell Adds Another Collaboration, Targets Home COVID-19 Testing With BD

Scanwell Health, a leader in smartphone-enabled home diagnostics tests, has announced a partnership with Beckton Dickson.  

Topics

Related Companies

UsernamePublicRestriction

Register

LL1135866

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel